Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,930,567
+$37,985 QoQ
Shares Held
31,461
-1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#264
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 4%
None 4%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COMMERCE BANK holds $977,076,250 across 13 Drug Manufacturers - General names. NVS ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
990,481 | $251,552,457 | |
| 2 | LLY |
ELI LILLY & Co
|
196,251 | $235,389,356 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,238,538 | $159,152,132 | |
| 4 | ABBV |
AbbVie Inc.
|
534,937 | $134,611,546 | |
| 5 | AMGN |
Amgen Inc
|
256,448 | $92,864,949 | |
| 6 | PFE |
Pfizer Inc
|
1,666,812 | $40,136,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
281,297 | $35,539,062 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
280,150 | $16,142,242 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,930,567 | 31,461 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,892,582 | 32,030 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,116,413 | 22,604 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,839,617 | 22,143 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,636,202 | 21,785 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $2,654,672 | 23,813 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $2,066,085 | 21,232 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,488,687 | 21,637 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,294,744 | 21,555 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,100,200 | 21,712 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,254,255 | 22,326 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,274,736 | 22,332 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,222,542 | 22,025 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,067,976 | 22,478 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,036,118 | 22,444 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,786,538 | 23,504 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,898,036 | 22,454 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,951,910 | 22,244 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,000,700 | 22,873 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,024,545 | 24,756 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,367,220 | 25,945 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,209,657 | 25,850 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $2,360,182 | 24,994 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,182,956 | 25,103 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $3,073,581 | 35,191 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,952,168 | 23,677 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||